ロード中...

Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores

PURPOSE: PR loss in ER+/HER2- breast cancer indicates worse prognosis and insensitivity to anti-estrogen therapy, while the mechanisms of PR loss in ER+/HER2- breast cancer remain unrevealed. METHODS: In this study, ER+/PR+/HER2- and ER+/PR-/HER2- breast cancer cases from TCGA were used. 1387 pathwa...

詳細記述

保存先:
書誌詳細
出版年:BMC Med Res Methodol
主要な著者: Hu, Taobo, Chen, Yan, Liu, Yiqiang, Zhang, Danhua, Pan, Jiankang, Long, Mengping
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8141178/
https://ncbi.nlm.nih.gov/pubmed/34022815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-021-01297-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!